Srishti Shrestha

Dr. Srishti Shrestha


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2023 in American Journal of Epidemiology
Verified
Journal Article
Closed access
PDF file
SSSrishti Shrestha
Srishti Shrestha
XZXiaoqian Zhu
Xiaoqian Zhu
SLStephanie J London
Stephanie J London
KSKevin J Sullivan
Kevin J Sullivan
PLPamela L Lutsey
Pamela L Lutsey
TJThomas H Mosley Jr
Thomas H Mosley Jr
We examined the associations between lung function and incident dementia and cognitive decline in 12,688 participants in the ARIC Study who provided lung function measurements in 1990–1992. Cognitive tests were administered up to 7 times, and dementia was ascertained through 2019. We used shared parameter models to jointly fit proportional hazard models and linear mixed-effect models to estimate lung-function–associated dementia rate and cognitive change, respectively. Higher forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) were associated with reduced dementia (n = 2,452 persons developed dementia); hazard ratios per 1-L increase in FEV1 and FVC were 0.79 (95% confidence interval (CI): 0.71, 0.89) and 0.81 (95% CI: 0.74, 0.89), respectively. Each 1-L increase in FEV1 and FVC was associated with a 0.08–standard deviation (SD) (95% CI: 0.05, 0.12) and a 0.05-SD (95% CI: 0.02, 0.07) attenuation of 30-year cognitive decline, respectively. A 1% increase in FEV1/FVC ratio was associated with 0.008-SD (95% CI: 0.004, 0.012) less cognitive decline. We observed statistical interaction between FEV1 and FVC, suggesting that cognitive declines depended on values of specific FEV1 and FVC (as compared with FEV1, FVC, or FEV1/FVC ratio models that suggested linear incremental associations). Our findings may have important implications for reducing the burden of cognitive decline that is attributable to environmental exposures and associated lung function impairment.

16 December 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
AAAniqa Alam
Aniqa Alam
DTDaNashia S. Thomas
DaNashia S. Thomas
PLPamela Lutsey
Pamela Lutsey
SSSrishti Shrestha
Srishti Shrestha
AAAlvaro Alonso
Alvaro Alonso
Circulating magnesium has been associated with a lower risk of dementia, but the physiologic effects by which magnesium may prevent neurological insults remain unclear. We studied 1466 individuals (mean age 76.2 ± 5.3, 28.8% black, 60.1% female) free of prevalent stroke, with measured serum magnesium and with available MRI scans obtained in 2011–2013, participating in the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). Cross-sectional differences in frontal, temporal, parietal, and occipital lobe volume, along with deep grey matter, total brain, and white matter hyperintensity volume across serum magnesium (categorized into quintiles and per standard deviation increases) were assessed using multiple linear regression. We also examined associations of magnesium with the prevalence of cortical, subcortical, and lacunar infarcts using multiple logistic regression. After adjusting for demographics, biomarkers, medications, and cardiometabolic risk factors, higher circulating magnesium was associated with greater total brain volume and frontal, temporal, and parietal lobe volumes (volumes 0.14 to 0.19 standard deviations higher comparing Q5 to Q1). Elevated magnesium was also associated with lower odds of subcortical infarcts (OR (95%CI): 0.44 (0.25, 0.77) comparing Q5 to Q1) and lacunar infarcts (OR (95%CI): 0.40 (0.22, 0.71) comparing Q5 to Q1). Elevated serum magnesium was cross-sectionally associated with greater brain volumes and lower odds of subclinical cerebrovascular disease, suggesting beneficial effects on pathways related to neurodegeneration and cerebrovascular damage. Further exploration through prospective analyses is needed to assess increasing circulating magnesium as a potential neuroprotective intervention.

19 August 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
SSSrishti Shrestha
Srishti Shrestha
XZXiaoqian Zhu
Xiaoqian Zhu
VKVidyulata Kamath
Vidyulata Kamath
KSKevin J. Sullivan
Kevin J. Sullivan
JDJennifer A. Deal
Jennifer A. Deal
HCHonglei Chen
Honglei Chen
Olfactory function has significant implications for human health, but few risk factors for olfactory decline have been identified. We examined the factors associated with olfactory status and decline over five years in the Atherosclerosis Risk in Communities (ARIC) Neurocognitive Study. A 12-item odor identification test was used to assess olfaction in 6053 participants in 2011–2013 (ARIC visit 5, mean age: 75.6, 41% male, 23% Black race) and in 3235 participants in 2016–2017 (visit 6). We used Poisson regression models to examine cross-sectional associations of a range of potential factors with the total odor identification errors (mean errors: 2.8 ± 2.4) in visit 5 participants. We used mixed-effect Poisson regression to examine associations with olfactory decline between visits 5 and 6. We also examined associations with visit 5 anosmia prevalence (847 cases, 14%) and incident anosmia between the two visits (510 cases, 16%) using Poisson models. Older age, male sex, lower education, Black race, APOE ε4 alleles, and diabetes were associated with higher odor identification errors and higher anosmia prevalence, and greater physical activity and hypertension with better olfaction. Age, male sex, lower education, Black race, APOE ε4 allele, and vitamin B12 levels were associated with incident anosmia over 5 years. Older age was associated with faster olfactory decline. Future studies with longer follow-ups are warranted.

25 June 2024 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
SSSrishti Shrestha
Srishti Shrestha
XZXiaoqian Zhu
Xiaoqian Zhu
KSKevin J Sullivan
Kevin J Sullivan
JSJeannette Simino
Jeannette Simino
PLPamela L Lutsey
Pamela L Lutsey
TMThomas H Mosley
Thomas H Mosley
Background: Brain imaging studies may provide etiologic insight into observed links between lung function and dementia and stroke. Objective: We evaluated associations of lung function measures with brain MRI markers of vascular and neurodegenerative disease in the ARIC Neurocognitive Study, as few studies have examined the associations. Methods: Lung function was measured at participants’ midlife in 1990–1992 (mean age = 56±5 years) and later-life in 2011–2013 (mean age = 76±5 years), and brain MRI was performed in 2011–2013. Linear regression models were used to examine the associations of lung function with brain and white matter hyperintensity (WMH) volumes, and logistic regression models were used for cerebral infarcts and microbleeds, adjusting for potential confounders. Results: In cross-sectional analysis (i.e., examining later-life lung function and MRI markers, n = 1,223), higher forced-expiratory volume in one second (FEV1) and forced vital capacity (FVC) were associated with larger brain and lower WMH volumes [e.g., 8.62 (95% CI:2.54–14.71) cm3 greater total brain volume per one-liter higher FEV1]. No association was seen with microbleeds in the overall sample, but higher FVC was associated with lower odds of microbleeds in never-smokers and higher odds in ever-smokers. In the cross-temporal analysis (i.e., associations with midlife lung function, n = 1,787), higher FVC levels were significantly associated with lower later-life brain volumes. Conclusions: Our results support modest associations of better lung function with less neurodegenerative and cerebrovascular pathology, although findings for microbleeds were unexpected in ever-smokers.

26 September 2023 in Neurology
Verified
Journal Article
Closed access
PDF file
SSSrishti Shrestha
Srishti Shrestha
XZXiaoqian Zhu
Xiaoqian Zhu
KSKevin J. Sullivan
Kevin J. Sullivan
CBChad Blackshear
Chad Blackshear
JDJennifer A. Deal
Jennifer A. Deal
TMThomas H. Mosley
Thomas H. Mosley
Objectives: Research on olfaction and brain neuropathology may help understand brain regions associated with normal olfaction and dementia pathophysiology. To identify early regional brain structures affected in poor olfaction, we examined cross-sectional associations of microstructural integrity of the brain with olfaction in the Atherosclerosis Risk in Communities Neurocognitive Study. Methods: Participants were selected from a prospective cohort study of community-dwelling adults; selection criteria included: evidence of cognitive impairment, participation in a previous MRI study, and a random sample of cognitively normal participants. Microstructural integrity was measured by two diffusion tensor imaging (DTI) measures, fractional anisotropy (FA) and mean diffusivity (MD), and olfaction by a 12-item odor-identification test at the same visit. Higher FA and MD values indicate better and worse microstructural integrity, respectively, and higher odor-identification scores indicate better olfaction. We used brain region-specific linear regression models to examine associations between DTI measures and olfaction, adjusting for potential confounders. Results: Among 1,418 participants (mean age: 76±5years, 41% male, 21% Black race, 59% with normal cognition), the mean olfaction score was 9±2.3. Relevant to olfaction, higher MD in the medial temporal lobe (MTL) regions, namely, the hippocampus (β: -0.79 (95%CI: -0.94, -0.65) units lower olfaction score per SD higher MD), amygdala, entorhinal area, and some white matter (WM) tracts connecting to these regions, was associated with olfaction. We also observed associations with MD and WM FA in multiple atlas regions that were not previously implicated in olfaction. The associations between MD and olfaction were particularly stronger in the MTL regions among individuals with mild cognitive impairment (MCI) compared to those with normal cognition (e.g., βhippocampus: -0.75 (95%CI: -1.02, -0.49) and -0.44 (95%CI: -0.63, -0.26) for MCI and normal cognition, respectively, p-interaction=0.004). Conclusions: Neuronal microstructural integrity in multiple brain regions, in particular the MTL (the regions known to be affected in early Alzheimer’s), is associated with odor-identification ability. Differential associations in the MTL regions among cognitively normal individuals compared to those with MCI may reflect the earlier vs. later effects of the dementia pathogenesis. It is likely that some of the associated regions may not have any functional relevance to olfaction.

23 February 2025 in Alzheimer's & Dementia
Verified
Journal Article
Open access
SSSrishti Shrestha
Srishti Shrestha
XZXiaoqian Zhu
Xiaoqian Zhu
AKAnna M. Kucharska‐Newton
Anna M. Kucharska‐Newton
YYYaqun Yuan
Yaqun Yuan
VKVidyulata Kamath
Vidyulata Kamath
HCHonglei Chen
Honglei Chen
INTRODUCTION: Few studies have characterized the association of olfaction with dementia in detail across diverse sociodemographic subgroups. METHODS: We examined the association of one‐time‐point olfactory status with incident dementia overall and by age, race, sex, and apolipoprotein E ( APOE) ε4 status ( n = 4470, mean age: 75 ± 5 years, 21% Black), and 5‐year olfactory change with incident dementia ( n = 2658) in the community‐based Atherosclerosis Risk in Communities (ARIC) study. RESULTS: Compared to good olfaction, moderate olfaction (hazard ratio [HR]: 1.53, 95% confidence interval [CI]: 1.26 to 1.86), hyposmia (HR: 2.24, 95% CI: 1.81 to 2.78), and anosmia (HR: 3.47, 95% CI: 2.77 to 4.34) were all associated with higher dementia hazard; these associations were consistent across age, race, sex, and APOE ε4 groups. The absolute risk difference between anosmia and good olfaction was higher in APOE ε4 carriers than in non‐carriers. Those with stable anosmia and converting from normal olfaction to anosmia over time showed particularly strong associations. DISCUSSION: Olfactory impairment was robustly associated with incident dementia, with strongest associations in those with persistent impairment and greater olfactory decline over ∼5 years. Highlights: We examined olfactory status and olfactory change in relation to incident dementia. Poor olfactory status was robustly associated with higher dementia rate. Associations were robust across subgroups of age, sex, race, and APOE ε4 status. Persistent poor olfaction or decline over time showed the strongest associations.